Cargando…
Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
Antibiotic disruption of the intestinal microbiota may cause susceptibility to pathogens that is resolved by progressive bacterial outgrowth and colonization. Succession is central to ecological theory but not widely documented in studies of the vertebrate microbiome. Here, we study succession in th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468616/ https://www.ncbi.nlm.nih.gov/pubmed/23071679 http://dx.doi.org/10.1371/journal.pone.0046966 |
_version_ | 1782245972419543040 |
---|---|
author | Peterfreund, Gregory L. Vandivier, Lee E. Sinha, Rohini Marozsan, Andre J. Olson, William C. Zhu, Jun Bushman, Frederic D. |
author_facet | Peterfreund, Gregory L. Vandivier, Lee E. Sinha, Rohini Marozsan, Andre J. Olson, William C. Zhu, Jun Bushman, Frederic D. |
author_sort | Peterfreund, Gregory L. |
collection | PubMed |
description | Antibiotic disruption of the intestinal microbiota may cause susceptibility to pathogens that is resolved by progressive bacterial outgrowth and colonization. Succession is central to ecological theory but not widely documented in studies of the vertebrate microbiome. Here, we study succession in the hamster gut after treatment with antibiotics and exposure to Clostridium difficile. C. difficile infection is typically lethal in hamsters, but protection can be conferred with neutralizing antibodies against the A and B toxins. We compare treatment with neutralizing monoclonal antibodies (mAb) to treatment with vancomycin, which prolongs the lives of animals but ultimately fails to protect them from death. We carried out longitudinal deep sequencing analysis and found distinctive waves of succession associated with each form of treatment. Clindamycin sensitization prior to infection was associated with the temporary suppression of the previously dominant Bacteroidales and the fungus Saccinobaculus in favor of Proteobacteria. In mAb-treated animals, C. difficile proliferated before joining Proteobacteria in giving way to re-expanding Bacteroidales and the fungus Wickerhamomyces. However, the Bacteroidales lineages returning by day 7 were different from those that were present initially, and they persisted for the duration of the experiment. Animals treated with vancomycin showed a different set of late-stage lineages that were dominated by Proteobacteria as well as increased disparity between the tissue-associated and luminal cecal communities. The control animals showed no change in their gut microbiota. These data thus suggest different patterns of ecological succession following antibiotic treatment and C. difficile infection. |
format | Online Article Text |
id | pubmed-3468616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34686162012-10-15 Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile Peterfreund, Gregory L. Vandivier, Lee E. Sinha, Rohini Marozsan, Andre J. Olson, William C. Zhu, Jun Bushman, Frederic D. PLoS One Research Article Antibiotic disruption of the intestinal microbiota may cause susceptibility to pathogens that is resolved by progressive bacterial outgrowth and colonization. Succession is central to ecological theory but not widely documented in studies of the vertebrate microbiome. Here, we study succession in the hamster gut after treatment with antibiotics and exposure to Clostridium difficile. C. difficile infection is typically lethal in hamsters, but protection can be conferred with neutralizing antibodies against the A and B toxins. We compare treatment with neutralizing monoclonal antibodies (mAb) to treatment with vancomycin, which prolongs the lives of animals but ultimately fails to protect them from death. We carried out longitudinal deep sequencing analysis and found distinctive waves of succession associated with each form of treatment. Clindamycin sensitization prior to infection was associated with the temporary suppression of the previously dominant Bacteroidales and the fungus Saccinobaculus in favor of Proteobacteria. In mAb-treated animals, C. difficile proliferated before joining Proteobacteria in giving way to re-expanding Bacteroidales and the fungus Wickerhamomyces. However, the Bacteroidales lineages returning by day 7 were different from those that were present initially, and they persisted for the duration of the experiment. Animals treated with vancomycin showed a different set of late-stage lineages that were dominated by Proteobacteria as well as increased disparity between the tissue-associated and luminal cecal communities. The control animals showed no change in their gut microbiota. These data thus suggest different patterns of ecological succession following antibiotic treatment and C. difficile infection. Public Library of Science 2012-10-10 /pmc/articles/PMC3468616/ /pubmed/23071679 http://dx.doi.org/10.1371/journal.pone.0046966 Text en © 2012 Peterfreund et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Peterfreund, Gregory L. Vandivier, Lee E. Sinha, Rohini Marozsan, Andre J. Olson, William C. Zhu, Jun Bushman, Frederic D. Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile |
title | Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
|
title_full | Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
|
title_fullStr | Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
|
title_full_unstemmed | Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
|
title_short | Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile
|
title_sort | succession in the gut microbiome following antibiotic and antibody therapies for clostridium difficile |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468616/ https://www.ncbi.nlm.nih.gov/pubmed/23071679 http://dx.doi.org/10.1371/journal.pone.0046966 |
work_keys_str_mv | AT peterfreundgregoryl successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile AT vandivierleee successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile AT sinharohini successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile AT marozsanandrej successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile AT olsonwilliamc successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile AT zhujun successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile AT bushmanfredericd successioninthegutmicrobiomefollowingantibioticandantibodytherapiesforclostridiumdifficile |